일회용 수술 장갑 시장 : 제품 유형, 소재, 최종 사용자, 유통 채널별 예측(2026-2032년)

The Disposable Surgical Gloves Market is projected to grow by USD 16.48 billion at a CAGR of 11.18% by 2032.

Disposable surgical gloves are a critical infection-prevention product used to create a sterile barrier between surgical teams and patients. Demand is anchored by operating-room procedure volumes, hospital-acquired infection prevention programs, and regulatory requirements for sterile, single-use medical devices.

The market is shaped by material selection, with natural rubber latex, nitrile, neoprene, and polyisoprene competing on tactile sensitivity, allergy management, chemical resistance, puncture performance, and cost. For manufacturers, the strongest opportunities are tied to consistent quality, validated sterility, resilient sourcing, and compliance with recognized standards and regulations, including ASTM performance requirements, EN 455, ISO 11193, U.S. FDA medical glove requirements, and the European Union Medical Device Regulation.

Transformative Shifts in the Surgical Gloves Landscape

The disposable surgical gloves landscape is shifting from volume-led procurement toward risk-based sourcing, traceability, and clinically validated performance. Hospitals, ambulatory surgical centers, and group purchasing organizations are increasingly evaluating suppliers on continuity of supply, documented quality systems, low defect rates, and the ability to support latex-safe environments.

Material innovation is another defining shift. Powdered medical gloves are restricted or banned in major markets such as the United States because of patient and clinician safety concerns, while powder-free synthetic materials are expanding where latex allergy risk, supply volatility, and chemical exposure influence purchasing decisions. Sustainability is also gaining importance as healthcare systems assess waste reduction, packaging efficiency, responsible raw material sourcing, and lower-impact manufacturing without compromising sterility or barrier protection.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to reshape surgical glove manufacturing through computer vision inspection, anomaly detection, predictive maintenance, and process optimization. These tools can help identify pinholes, surface defects, thickness variation, form-line irregularities, and packaging inconsistencies faster than manual sampling alone, supporting higher process control and fewer nonconforming batches.

AI also has cumulative impact beyond the factory floor. Planning models can integrate procedure volumes, public health signals, seasonal infection trends, hospital inventory data, and supplier lead-time variability to improve production scheduling and allocation. For regulated manufacturers, AI-enabled documentation, supplier-risk monitoring, complaint categorization, and post-market signal detection can strengthen surveillance while supporting faster corrective and preventive action workflows, provided validation, data integrity, and human oversight remain central.

Key Regional Insights

Asia-Pacific remains central to disposable surgical glove supply because Malaysia, Thailand, China, and India have established glove, rubber, petrochemical, and medical manufacturing ecosystems. Regional demand is also rising across China, India, Japan, South Korea, and Australia as surgical capacity, private healthcare investment, medical tourism, and infection-control standards expand. North America is driven by high surgical utilization, strict U.S. FDA and Health Canada oversight, and renewed emphasis on domestic and nearshore medical supply resilience following pandemic-era supply disruptions.

Europe is shaped by EU MDR compliance, EN 455 performance expectations, hospital tender discipline, and sustainability-linked procurement across public health systems. Latin America is led by Brazil and Mexico through hospital modernization, expanding surgical access, and import-reliant demand for sterile consumables. The Middle East, particularly GCC markets, benefits from hospital expansion, medical tourism, and centralized purchasing, whereas Africa's development is tied to infection-prevention investment, donor and public procurement, workforce training, and improving access to sterile surgical consumables across tertiary and district-level care settings.

Key Group Insights

ASEAN is strategically important because it combines major production capacity with growing intra-regional healthcare demand, especially in Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. Its relevance is reinforced by rubber-processing expertise, export-oriented manufacturing, and expanding hospital infrastructure. GCC countries represent premium institutional buyers with centralized procurement, strong hospital infrastructure, and healthcare diversification programs, while the European Union sets a high bar for quality documentation, clinical safety, traceability, and sustainability under harmonized medical device rules.

BRICS markets are important for scale, with China, India, and Brazil supporting both demand expansion and manufacturing localization, while Russia and South Africa remain influenced by public procurement and supply security priorities. G7 countries influence premium standards, regulatory expectations, reimbursement-linked hospital purchasing, and resilient supply-chain initiatives. NATO members increasingly view medical consumables, including sterile surgical gloves, through the lens of emergency preparedness, defense healthcare readiness, pandemic response capacity, and secure procurement for civilian and military medical systems.

Key Country Insights

The United States leads premium demand through large hospital networks, FDA-regulated medical device purchasing, high procedural intensity, and strong infection-prevention governance, while Canada emphasizes public procurement reliability, supplier qualification, and quality assurance. Mexico supports nearshoring opportunities, cross-border distribution, and growing private healthcare demand, and Brazil remains Latin America's largest healthcare market with ANVISA-regulated demand and public-private hospital procurement. In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize sterile product performance, MDR-aligned documentation, surgeon comfort, and hospital tender competitiveness, while Russia's market is shaped by import substitution, currency-sensitive purchasing, and public procurement priorities.

China and India combine large procedure volumes with local manufacturing ambitions, expanding hospital networks, and policy support for medical device self-reliance. Japan prioritizes high-quality sterile gloves, precise sizing, clinician comfort, and rigorous supplier qualification within a mature healthcare system. Australia emphasizes compliance, dependable import channels, and strong infection-control standards across public and private facilities, while South Korea is driven by advanced hospital infrastructure, medical technology adoption, and stringent expectations for sterile surgical consumables used in high-acuity care.

Actionable Recommendations for Industry Leaders

Industry leaders should strengthen dual- and multi-source supply models, qualify backup raw material suppliers, and maintain documented business-continuity plans for sterile surgical glove production. Supplier audits, lot traceability, validated sterilization controls, and packaging integrity should be treated as commercial differentiators, not only compliance obligations.

Manufacturers should invest in AI-enabled quality inspection, automation, predictive maintenance, and digital batch records while maintaining human oversight for regulated decisions. Product portfolios should include latex and synthetic sterile options, ergonomic sizing, powder-free designs, low-protein latex alternatives where applicable, and packaging that supports aseptic presentation. Commercial teams should align messaging with surgeon safety, infection prevention, regulatory readiness, material transparency, and supply reliability.

Research Methodology

This executive summary is developed using a structured secondary-research approach focused on verified industry, regulatory, clinical, and standards-based sources. Key inputs include medical device regulations, public health guidance, standards frameworks, procurement practices, trade patterns, product safety requirements, and documented shifts in healthcare supply-chain strategy.

The analysis evaluates market drivers through material trends, end-user requirements, regional healthcare infrastructure, manufacturing concentration, regulatory benchmarks, infection-prevention priorities, and supply-chain resilience indicators. Insights are synthesized to support executive decision-making without relying on unverified market-size claims, ensuring that conclusions remain grounded in observable industry dynamics and authoritative public information.

Conclusion

The disposable surgical gloves market is evolving from a commodity purchasing category into a strategic healthcare resilience and patient-safety priority. Sterility, barrier protection, allergen management, supply continuity, clinician comfort, and regulatory documentation are now central to competitive positioning.

Manufacturers that combine validated quality, synthetic material innovation, AI-supported operations, and regionally resilient sourcing will be best positioned to serve hospitals, surgical centers, and public health systems. The strongest opportunities will come from balancing cost discipline with clinically trusted performance, transparent compliance, and reliable access to sterile surgical gloves during routine care and emergency demand surges.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Disposable Surgical Gloves Market, by Product Type

• 7.1. Sterile Surgical Gloves
• 7.2. Non-Sterile Surgical Gloves
• 7.3. Powdered Surgical Gloves
• 7.4. Powder-Free Surgical Gloves
• 7.5. Textured Surgical Gloves

8. Disposable Surgical Gloves Market, by Material

• 8.1. Natural Rubber Latex
• 8.2. Neoprene
• 8.3. Nitrile
• 8.4. Polyisoprene
• 8.5. Vinyl

9. Disposable Surgical Gloves Market, by End User

• 9.1. Ambulatory Surgical Center
• 9.2. Diagnostic Laboratory
• 9.3. Hospital
  • 9.3.1. Private Hospital
  • 9.3.2. Public Hospital
• 9.4. Research Institute

10. Disposable Surgical Gloves Market, by Distribution Channel

• 10.1. Drug Store
• 10.2. Hospital Pharmacy
  • 10.2.1. In-House Pharmacy
  • 10.2.2. Third-Party Pharmacy
• 10.3. Industrial Distributor
• 10.4. Online Retail
  • 10.4.1. E-Commerce Marketplace
  • 10.4.2. Manufacturer Website

11. Disposable Surgical Gloves Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Disposable Surgical Gloves Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Disposable Surgical Gloves Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. 3M Company
• 15.2. Abbott Laboratories
• 15.3. Anhui Tianyuan Latex Technology Co.,Ltd.
• 15.4. Ansell Limited
• 15.5. Asma Rubber Products Pvt. Ltd.
• 15.6. B. Braun SE
• 15.7. Becton Dickinson and Company
• 15.8. Berner International GmbH
• 15.9. Boston Scientific Corporation
• 15.10. Cardinal Health Inc.
• 15.11. Crown Healthcare Ltd.
• 15.12. Cypress Medical Products LLC
• 15.13. Dynarex Corporation
• 15.14. Harps Holdings Sdn. Bhd
• 15.15. Honeywell International Inc.
• 15.16. Kimberly-Clark Corporation
• 15.17. Kossan Rubber Industries Bhd.
• 15.18. Medisafe Technologies
• 15.19. Medline Industries, Inc.
• 15.20. Medtronic PLC
• 15.21. Motex Healthcare Corporation
• 15.22. Molnlycke Health Care AB
• 15.23. Sara Healthcare Pvt. Ltd.
• 15.24. SHOWA Group
• 15.25. Smart Glove Corporation Sdn Bhd.
• 15.26. Supermax Corporation Berhad